Sarepta to Charge $300K for Duchenne Drug

September 19, 2016

In an interview with Ed Silverman of Statnews, Dr. Gellad discusses the new Sarepta Therapeutics Drug for Duchenne Muscular Dystrophy, coming in at roughly $300,00 per year for patients.